Derick H. M. Lau, MD, PhD

Articles by Derick H. M. Lau, MD, PhD

Evolution of Combined Modality Therapy for Stage III Non–Small-Cell Lung Cancer

ByDavid R. Gandara, MD,Martin Edelman, MD,Primo N. Lara, Jr, MD,Derick H. M. Lau, MD, PhD,Peter Roberts, MD,Bryan R. Leigh, MD

July 2nd 2000

A number of randomized clinical trials and meta-analyses now support the conclusion that combined modality regimens that include cisplatin (Platinol)-based chemotherapy improve survival in stage III non–small-cell lung

Latest Updated Articles

Evolution of Combined Modality Therapy for Stage III Non–Small-Cell Lung Cancer
Published: July 2nd 2000 | Updated:

Home

About Us

News